How Benefit Sharing Agreements Work in African Ethnobotany 2026

A benefit sharing agreement is the legally binding contract that sets the terms on which a researcher, university or company may use genetic material or traditional knowledge from another country, and states in advance what the people who supplied that knowledge receive in return. It works through two linked halves: prior informed consent, where the knowledge holders freely say yes after being told exactly what will happen, and mutually agreed terms, where both sides write down scope, benefits, credit, monitoring and dispute rules.

This guide explains how those agreements are put together, who signs them, what they contain, and how a community can check that the promises were kept. It is written for students, field researchers, herbal practitioners and small enterprises working with African medicinal plants.

What Are Benefit Sharing Agreements?

A benefit sharing agreement is the document you sign when you take something from a community’s biological or cultural heritage and build on it. That something might be a root bark collected during an ethnobotanical survey, a seed from a wild population, or the knowledge that a particular preparation is used for a particular complaint.

Three things define it. First, it is a contract, not a courtesy letter. Second, it is negotiated, not imposed, and the terms have to be written down so nobody has to rely on memory three years later. Third, it exists because national law requires it, usually under a country’s implementation of the Nagoya Protocol to the Convention on Biological Diversity.

The Nagoya Protocol was adopted in 2010 and entered into force on 12 October 2014. It sits underneath the 1992 Convention on Biological Diversity and turns its third objective, the fair and equitable sharing of benefits from the use of genetic resources, into something a project can be held to.

In plain terms: access is a permission, and benefit sharing is the price of that permission, agreed by both sides rather than extracted by one.

Why Are Benefit Sharing Agreements Important?

Without a documented agreement, a plant or a piece of ancestral knowledge can be collected, analysed, patented and sold on a shelf in another continent with nothing returned to the people who supplied it. The Convention calls that biopiracy, and the cases people still argue about, from Hoodia gordonii to the Cocculus hirsutus arrangement in Madhya Pradesh, all share the same shape: value extracted on one side, nothing returned on the other.

The Convention on Biological Diversity has three objectives, and they explain most of what agreements are trying to fix:

1. Conservation of biological diversity.
2. Sustainable use of its components.
3. Fair and equitable sharing of benefits arising from the utilisation of genetic resources.

For a research project there are practical reasons too. Grant funders increasingly ask for evidence of lawful access. Universities need defensible research ethics approval. Journals want to know a field collection was lawful. And the community gets something it rarely had before, which is a seat at the table where the money is discussed.

Agreements also protect the researcher. A signed agreement with a recognised authority is the document that proves a project was done properly when a patent office, a journal or a regulator asks five years later.

Who Participates in the Agreement?

The signature list is longer than most people expect, and the groups below do not all have the same power or the same interest.

Party	Interest	Decision-making role
Community members	Fair share of benefits, recognition, protection of cultural practices	Consulted and, where customary law applies, decisive on consent
Traditional authorities and elders	Respect for protocol, continuity of cultural practice	Convene and validate the consent process
Healers and knowledge holders	Credit, respect, sometimes payment for specific knowledge	Grant or withhold access to particular knowledge
Researcher or institution	Legal access, publication, future products	Drafts and negotiates the terms
Funding body	Compliance, due diligence, reputational safety	Requires proof before releasing funds
National authority	Sovereignty over national genetic resources	Grants or refuses access, approves the agreement
Regulatory and ethics bodies	Research integrity, human and environmental safety	Approve the study separately from the agreement

Note the split between authority and knowledge. A national authority can permit access to a resource. It cannot grant knowledge that only a healer holds. When those two things come apart, projects stall.

How Benefit Sharing Agreements Work Step by Step

1. Scope the project honestly

Write down what you actually intend to do: which species, which parts, where you will collect, whether material leaves the country, and what you hope to make or publish from it. Vague proposals produce vague agreements and later disputes.

2. Check whether you are in scope

Ask the provider country’s national authority whether your use counts as utilisation. Collecting for a herbarium, a thesis or a commercial extract can all fall inside the rules depending on the country.

3. Identify the knowledge holders

Find out who actually holds the knowledge and who has the standing under customary law to agree to its use. Communities are not interchangeable, and neighbouring groups frequently disagree about the same forest.

4. Obtain free, prior and informed consent

This is the step that takes longest and cannot be skipped. Information must be in a language people speak, given before any request for a signature, and free of pressure. Consent given by a leader who never consulted the healers is not free, prior or informed.

5. Negotiate the mutually agreed terms

Both sides write the operative document: permitted uses, benefit package, intellectual property and publication rules, duration, monitoring, termination and dispute resolution.

6. Get the approvals the law requires

The national authority signs off, research ethics committees clear the study, and any collection permit is issued. These run in parallel, not in series.

7. Implement, report and pay

Money moves on the schedule in the agreement. Reports go to the community on the schedule too, not only to the funder in the capital.

8. Review, revise or wind down

Benefit packages are usually written with review dates. A project that stalls, a community that withdraws consent, or a company that loses interest all trigger a different route through the final clause.

How Is the Agreement Different From a Research Consent Form?

A consent form answers one question: may I do this study, and will you take part? It is short, it ends when the study ends, and it concerns the researchers and the participants.

A benefit sharing agreement answers a different set of questions: may I use this knowledge, for what, for how long, who owns what comes out of it, who gets named, who gets paid, and what happens if we disagree later. It usually outlives the study and can bind a company the researcher never works for again.

A consent form protects the participant. An agreement protects the relationship, and it protects the community’s claim to the knowledge itself, which a consent form never could.

What Can Count as a Benefit?

Benefits come in two broad shapes, and most serious agreements contain both.

Monetary benefits include an upfront access fee paid when permission is granted, milestone payments tied to specific research outcomes, royalties on any product that uses the material or knowledge, and funding for conservation work in the source area. Royalties only work if the agreement says who receives them and how they are calculated.

Non-monetary benefits include training for community members as research assistants, laboratory equipment left with a local clinic or school, results returned in plain language rather than only as a paywalled paper, co-authorship and joint research, recognition in publications and product labelling, long-term conservation funding, and access to resulting health products at cost.

Which of these matters most depends on what the community asked for, not on a template. A group that wants a clinic has no use for a training budget. Asking first is part of the process, and the answer belongs in the agreement even if the community wants nothing more than acknowledgement.

What Should the Agreement Include?

A workable benefit sharing agreement usually covers these clauses, in roughly this order:

• Purpose and scope: the research question, the species, the uses you intend, and the uses you exclude.
• Knowledge holders and communities: named parties, recognised by their own authority, not just by the researcher.
• Materials covered: species, parts, quantities, collection sites, and what happens to leftover material.
• Ownership and access: who may use the material, where it may be stored, and whether it can be passed on.
• Attribution: how the community and individual knowledge holders are named in every output.
• Benefit distribution: amounts, triggers, who receives them, who administers them, and how they are accounted for.
• Confidentiality: which knowledge stays within the community and may not be published.
• Commercialisation: patents, licences, products, and what the community gets if something reaches a market.
• Publication rights: review of manuscripts, veto over confidential material, timely reporting of negative results.
• Duration and termination: how long the agreement holds, and what happens if either side withdraws.
• Dispute resolution: negotiation first, then mediation, then a named forum.
• Review and revision: fixed dates to revisit terms that no longer fit.

The clauses worth arguing hardest over

Three do most of the work in practice. The benefit distribution clause decides whether money reaches the people who supplied the knowledge or disappears into an institutional budget. The confidentiality clause decides whether sacred or specialised knowledge is publishable at all. The termination clause decides whether a community can still say no after a patent has been filed.

A short agreement with three carefully drafted clauses usually serves a community better than a long one full of language nobody has explained to them.

How Are Traditional and Scientific Knowledge Treated?

Traditional knowledge is treated as something to be requested, documented with permission and credited, not as a free input. The Protocol asks that it be documented with the agreement of the knowledge holders, and that attribution and benefits flow from that use.

In practice that means the research questions get agreed rather than imposed. If a community does not want the cause of a particular illness published, that can be a term of the agreement rather than a favour. If a healer taught a preparation that ends up in a commercial product, the agreement decides whether and how they are named.

Scientific knowledge from the project is usually shared back through papers, datasets and training. Both kinds of knowledge keep their owners; neither becomes public property because it was written down.

What Happens If the Research Leads to a Product or Commercial Use?

This is where agreements earn their keep. A medicinal plant that enters a screening programme may end up in a standardised extract, a cosmetic ingredient or a patent filing years later, usually by a company the original researchers have never met.

The clauses to settle early are straightforward: who may apply for intellectual property rights over what, in which countries, and whether the community or the knowledge holder must be named as a co-inventor or co-owner. Whether the community shares in royalties or receives a one-off payment. Whether the source country gets access to the finished product at cost, and for how long. What happens to samples, seeds and voucher specimens left behind.

Getting these terms right is a legal job, not a drafting job. A research institution should involve qualified legal counsel and its technology transfer office before commercialisation, because provisions written by scientists rarely survive a patent dispute.

How Can Communities Review and Monitor the Agreement?

An agreement with no monitoring is a promise, not a contract. Communities usually monitor through existing structures rather than something invented for the project: a committee that already meets regularly, a traditional council, or a dedicated fund management group set up by the agreement itself.

What makes monitoring work is unglamorous. Agreed dates for written reports. Records of money received and money distributed, presented in a language everyone reads. Meetings where the research team shows up rather than sending a letter. A named contact on each side that a community member can reach directly.

Review clauses let terms change when circumstances do. A project that expands into a new country, a community that withdraws consent, a funder that pulls out: each of these should have a route written down in advance, while everyone still trusts each other.

Frequently Asked Questions

Conclusion: Start Before Research Begins

The action to take first is small and unglamorous: identify the people who hold the knowledge, ask the provider country’s authority whether your project is in scope, and start the conversation before you collect anything. Benefit sharing agreements work best when they are drafted with communities rather than presented to them, and when the hard clauses on attribution, confidentiality and withdrawal are settled while everyone still trusts each other.

As of 2026, the legal picture is still moving, particularly around digital sequence information. Treat the agreement as a living document that gets reviewed, not a box ticked on a permit application.